Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K191928

AccuContour

Xiamen Manteia Technology LTD.

Authorized purpose: AccuContour generates initial organ-at-risk contours from supported multimodality images for physician review in radiation-treatment planning and evaluation workflows.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2020-02-28